class name | count |
---|---|
rosids | 1016 |
eudicotyledons | 35 |
asterids | 23 |
Embryophyta | 12 |
Spermatophyta | 4 |
Magnoliophyta | 3 |
class name | count |
---|---|
Fabaceae | 1012 |
Berberidaceae | 25 |
Orobanchaceae | 16 |
Lycopodiaceae | 12 |
Cupressaceae | 4 |
Daphniphyllaceae | 4 |
Convolvulaceae | 4 |
Nymphaeaceae | 3 |
Viscaceae | 3 |
Styracaceae | 3 |
Amaranthaceae | 2 |
Euphorbiaceae | 1 |
Papaveraceae | 1 |
Anacardiaceae | 1 |
Rosaceae | 1 |
Nitrariaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Quinolizidine alkaloids | 31 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
---|---|---|---|---|---|---|---|
C00036283
![]() |
Dimethamine
|
No. 85 |
![]() |
||||
C00032558
![]() |
11,12-Seco-12,13-didehydromultiflorine
|
C058266
|
No. 85 |
![]() |
|||
C00007720
![]() |
N-Acetylcytisine
|
CHEMBL1513538
CHEMBL1553838 |
2 / 3 / 7 | No. 85 |
![]() |
||
C00026327
![]() |
Cernuine
|
No. 85 |
![]() |
||||
C00007718
![]() |
(-)-N-(N-Acetylaminomethyl)cytisine
|
No. 85 |
![]() |
||||
C00007717
![]() |
Sophorasine B
|
No. 85 |
![]() |
||||
C00026323
![]() |
4beta-Hydroxyepilupinine
|
No. 85 |
![]() |
||||
C00002209
![]() |
Dehydrolupanine
|
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
No. 85 |
![]() |
|||
C00026317
![]() |
(+/-)-Epilupinine
|
CHEMBL459397
CHEMBL1435718 |
1 / 1 / 1 | No. 85 |
![]() |
||
C00026314
![]() |
2,3-Dehydro-O-(2-pyrrolylcarbonyl)virgiline
|
No. 85 |
![]() |
||||
C00026313
![]() |
O-(2-Pyrrolylcarbonyl)-virgiline
|
No. 85 |
![]() |
||||
C00002213
![]() |
(-)-Camoensidine
|
No. 85 |
![]() |
||||
C00026312
![]() |
Calpaurine
|
No. 85 |
![]() |
||||
C00026311
![]() |
Calpurnine
/ Oroboidine |
C013362
|
0 / 3 | No. 85 |
![]() |
||
C00007716
![]() |
Sophorasine A
|
No. 85 |
![]() |
||||
C00026309
![]() |
Sessilifoline
|
No. 85 |
![]() |
||||
C00007714
![]() |
N-(3-Oxobutyl)cytisine
|
CHEMBL190851
|
4 / 3 / 1 | No. 85 |
![]() |
||
C00026308
![]() |
Digittine
/ 4beta-Hydroxycalpurnine / 4beta-Hydroxy-13alpha-O-(2'-pyrrolylcarbonyl)lupanine |
No. 85 |
![]() |
||||
C00026301
![]() |
Cinegalline
|
No. 85 |
![]() |
||||
C00002221
![]() |
13alpha-(Tigloyloxy)lupanine
|
No. 85 |
![]() |
||||
C00026291
![]() |
5,6-Dehydroisolupanine
|
No. 85 |
![]() |
||||
C00026289
![]() |
Multiflorine N-oxide
|
No. 85 |
![]() |
||||
C00002225
![]() |
d-Sophoridine
/ (+)-Sophoridine |
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
5 / 3 / 7 | No. 85 |
![]() |
||
C00026287
![]() |
Sophocarpine N-oxide
/ (+)-Sophocarpine N-oxide |
CHEMBL380410
|
C046246
|
No. 85 |
![]() |
||
C00002227
![]() |
(+)-Darvasamine
|
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
5 / 3 / 7 | No. 85 |
![]() |
||
C00026286
![]() |
(+)-Sophoranol N-oxide
|
No. 85 |
![]() |
||||
C00002229
![]() |
9alpha-Hydroxymatrine
/ (+)-9alpha-Hydroxymatrine |
CHEMBL204747
|
No. 85 |
![]() |
|||
C00026284
![]() |
Camoensidine N-oxide
|
No. 85 |
![]() |
||||
C00007713
![]() |
(-)-N-(3-Oxobutyl)cytisine
|
CHEMBL190851
|
4 / 3 / 1 | No. 85 |
![]() |
||
C00026280
![]() |
Oxymatrine
/ Ammothamnine / Matrine N-oxide / (+)-Matrine N-oxide / Matrine 1beta-oxide |
CHEMBL458337
CHEMBL1358502 |
C037573
|
3 / 11 / 6 | 0 / 4 | No. 85 |
![]() |
C00007712
![]() |
Rhombifoline
/ (-)-Rhombifoline |
CHEMBL1397610
|
C119591
|
No. 85 |
![]() |
||
C00007704
![]() |
Cytisine
/ (-)-Cytisine |
CHEMBL47039
CHEMBL497939 CHEMBL1628606 |
C004712
|
27 / 36 / 33 | 6 / 1 | No. 85 |
![]() |
C00026268
![]() |
N-(Methoxycarbonyl)angustifoline
|
No. 85 |
![]() |
||||
C00026267
![]() |
N-Formylangustifoline
|
No. 85 |
![]() |
||||
C00026264
![]() |
Isoangustifoline
|
CHEMBL459206
|
No. 85 |
![]() |
|||
C00026263
![]() |
Dehydroretamine
|
No. 85 |
![]() |
||||
C00023313
![]() |
5,6-Dehydro-alpha-isolupanine
|
No. 85 |
![]() |
||||
C00007781
![]() |
2(S)-Hydroxyaphyllidine
|
No. 85 |
![]() |
||||
C00007765
![]() |
Multiflorine
/ (-)-Multiflorine |
CHEMBL517095
|
No. 85 |
![]() |
|||
C00007764
![]() |
(-)-13alpha-Hydroxy-4-oxosparteine
|
No. 85 |
![]() |
||||
C00007762
![]() |
Leontiformine
|
CHEMBL1476333
|
2 / 3 / 7 | No. 85 |
![]() |
||
C00007761
![]() |
Schoberine
|
No. 85 |
![]() |
||||
C00007757
![]() |
10alpha-Hydroxymethylsparteine
|
No. 85 |
![]() |
||||
C00007691
![]() |
Cadiamine
|
No. 85 |
![]() |
||||
C00007692
![]() |
5alpha-Hydroxysophocarpine
|
No. 85 |
![]() |
||||
C00007744
![]() |
11alpha-Allylcytisine
|
No. 85 |
![]() |
||||
C00007694
![]() |
4beta,13alpha-Dihydroxyupanine
|
No. 85 |
![]() |
||||
C00007701
![]() |
Dehydrocytisine B
/ (-)-Dehydrocytisine B |
CHEMBL47039
CHEMBL497939 CHEMBL1628606 |
27 / 36 / 33 | No. 85 |
![]() |
||
C00007698
![]() |
Dehydrocytisine A
/ (-)-Dehydrocytisine A |
CHEMBL47039
CHEMBL497939 CHEMBL1628606 |
27 / 36 / 33 | No. 85 |
![]() |
||
C00007738
![]() |
7alpha-Hydroxysophoramine
|
No. 376 |
![]() |
||||
C00007742
![]() |
Isotinctorine
|
No. 376 |
![]() |
||||
C00007725
![]() |
Baptifoline
/ (-)-Baptifoline |
C106940
|
No. 376 |
![]() |
|||
C00007737
![]() |
Sophoramine
|
C055681
|
No. 376 |
![]() |
|||
C00007736
![]() |
5,6-Dehydromultiflorine
|
No. 376 |
![]() |
||||
C00007735
![]() |
Thermopsine
/ (-)-Thermopsine |
CHEMBL203399
CHEMBL509692 CHEMBL1324708 CHEMBL1454284 |
C059560
|
7 / 8 / 11 | No. 376 |
![]() |
|
C00026276
![]() |
(-)-Sophoridine N-oxide
|
CHEMBL458337
CHEMBL1358502 |
3 / 11 / 6 | No. 376 |
![]() |
||
C00002234
![]() |
(+)-14alpha-Hydroxymatrine
|
No. 376 |
![]() |
||||
C00002218
![]() |
13-Oxolupanine
/ 13-Ketolupanine / 2,13-Dioxosparteine |
No. 376 |
![]() |
||||
C00002216
![]() |
Virgiline
|
No. 376 |
![]() |
||||
C00026325
![]() |
Anhydrolycocernuine
|
No. 376 |
![]() |
||||
C00026326
![]() |
Carolinianine
|
No. 376 |
![]() |
||||
C00007728
![]() |
(-)-Argentamine
/ (-)-13-Hydroxythermopsine |
No. 376 |
![]() |
||||
C00026339
![]() |
(+)-Epilamprolobine N-oxide
|
No. 376 |
![]() |
||||
C00007727
![]() |
Epibaptifoline
/ (-)-Epibaptifoline |
No. 376 |
![]() |
||||
C00007726
![]() |
13beta-Hydroxythermopsine
|
No. 376 |
![]() |
||||
C00026275
![]() |
Deoxoangustifoline
|
No. 376 |
![]() |
||||
C00007724
![]() |
Dehydrobaptifoline
|
No. 384 |
![]() |
||||
C00007723
![]() |
Ethyl 12-cytisineacetate
|
No. 384 |
![]() |
||||
C00007722
![]() |
N-Carbomethoxycytisine
/ 12-Carboxycytisine methyl ester |
No. 384 |
![]() |
||||
C00023310
![]() |
(+)-5,6-Dehydrolupanine
|
No. 384 |
![]() |
||||
C00026337
![]() |
9beta-Hydroxylamprolobine
|
No. 384 |
![]() |
||||
C00007729
![]() |
(-)-9alpha-Hydroxysophoramine
|
No. 384 |
![]() |
||||
C00025370
![]() |
5,6-Dehydro-alpha-isosparteine
|
No. 384 |
![]() |
||||
C00002207
![]() |
4-Hydroxylupanine
|
No. 384 |
![]() |
||||
C00026324
![]() |
Epilupinine acetate
|
No. 384 |
![]() |
||||
C00026320
![]() |
Tashiromine
|
No. 384 |
![]() |
||||
C00026319
![]() |
(-)-Lupinine
|
CHEMBL459397
CHEMBL1435718 |
C015971
|
1 / 1 / 1 | No. 384 |
![]() |
|
C00002212
![]() |
Lupanine
/ (+)-Lupanine |
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
C008298
|
No. 384 |
![]() |
||
C00002215
![]() |
3alpha-Hydroxylupanine
|
CHEMBL515231
|
No. 384 |
![]() |
|||
C00002239
![]() |
Dehydroaphylline
|
CHEMBL509343
|
No. 384 |
![]() |
|||
C00007750
![]() |
Retamine
|
No. 384 |
![]() |
||||
C00026270
![]() |
Virgiboidine
|
No. 384 |
![]() |
||||
C00026271
![]() |
Tetrahydrorhombifoline
|
CHEMBL460224
|
No. 384 |
![]() |
|||
C00002235
![]() |
14b-Hydroxymatrine
/ (-)-14beta-Hydroxymatrine |
No. 384 |
![]() |
||||
C00002238
![]() |
Epiaphylline
/ Dihydromonspessulanine / 0-Oxo-alpha-isosparteine / 17-Oxo-alpha-isosparteine |
CHEMBL509343
|
No. 384 |
![]() |
|||
C00007693
![]() |
3beta,13alpha-Dihydroxylupanine
|
No. 424 |
![]() |
||||
C00002236
![]() |
14beta-Hydroxymatrine
/ (-)-14beta-Hydroxymatrine |
No. 424 |
![]() |
||||
C00002233
![]() |
(-)-14beta-Hydroxysophoridine
|
No. 424 |
![]() |
||||
C00002228
![]() |
(+)-Albertamine
|
CHEMBL1672133
|
No. 424 |
![]() |
|||
C00026269
![]() |
N-(Ethoxycarbonyl)angustifoline
|
No. 424 |
![]() |
||||
C00002224
![]() |
Sophoridine
/ (-)-Sophoridine |
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
5 / 3 / 7 | No. 424 |
![]() |
||
C00026302
![]() |
13alpha-Cinnamoyloxylupanine
|
No. 424 |
![]() |
||||
C00007752
![]() |
beta-Isosparteine
|
CHEMBL412873
CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 |
93 / 50 / 48 | No. 424 |
![]() |
||
C00026265
![]() |
Angustifoline
|
CHEMBL459206
|
C101930
|
No. 424 |
![]() |
||
C00007681
![]() |
17-Oxosparteine
|
CHEMBL509343
|
C035707
|
No. 424 |
![]() |
||
C00007685
![]() |
6beta-Hydroxylupanine
|
No. 424 |
![]() |
||||
C00026260
![]() |
11,12-Dehydrosparteine
|
No. 424 |
![]() |
||||
C00026329
![]() |
Dihydrodeoxycernuine
|
No. 424 |
![]() |
||||
C00007684
![]() |
(-)-6alpha-Hydroxylupanine
|
No. 424 |
![]() |
||||
C00028974
![]() |
Griffithine
|
No. 424 |
![]() |
||||
C00007687
![]() |
(-)-6alpha-methoxylupanine
|
No. 424 |
![]() |
||||
C00007686
![]() |
(+)-Darvasoline
|
No. 424 |
![]() |
||||
C00007682
![]() |
Aphylline
|
CHEMBL509343
|
No. 424 |
![]() |
|||
C00026328
![]() |
Lycocernuine
|
No. 555 |
![]() |
||||
C00032562
![]() |
Deoxynupharidine
|
CHEMBL140239
CHEMBL140758 |
C010908
|
No. 555 |
![]() |
||
C00007743
![]() |
Tinctorine
/ (-)-Tinctorine |
No. 555 |
![]() |
||||
C00026330
![]() |
(-)-Epilamprolobine
|
No. 555 |
![]() |
||||
C00026306
![]() |
13alpha-Benzoyloxylupanine
|
No. 555 |
![]() |
||||
C00007688
![]() |
Sophoranol
|
No. 555 |
![]() |
||||
C00007689
![]() |
5alpha,9alpha-Dihydroxymatrine
|
No. 555 |
![]() |
||||
C00002219
![]() |
O-Methyljamaidine
/ 13-Epimethoxylupanine / 13-epi-Methoxylupanine / 13beta-Methoxylupanine / O-Methyl-13-epihydroxylupanine |
No. 555 |
![]() |
||||
C00025365
![]() |
11,12-Dehydrolupanine
/ 1,12-Didehydrolupanine |
No. 555 |
![]() |
||||
C00007696
![]() |
3beta,4alpha,13alpha-Trihydroxylupanine
|
No. 555 |
![]() |
||||
C00007747
![]() |
Thermopsamine
/ (+)-Thermopsamine |
No. 555 |
![]() |
||||
C00007748
![]() |
13-Hydroxysparteine
|
No. 555 |
![]() |
||||
C00007749
![]() |
14alpha-Hydroxysparteine
|
No. 555 |
![]() |
||||
C00002211
![]() |
(-)-Lupanine
|
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
No. 555 |
![]() |
|||
C00007690
![]() |
Pohakuline
/ (-)-Pohakuline |
No. 555 |
![]() |
||||
C00007756
![]() |
Dehydrosparteine
/ (-)-Dehydrosparteine |
CHEMBL412873
CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 |
93 / 50 / 48 | No. 1023 |
![]() |
||
C00007740
![]() |
O-Acetylbaptifolin
|
No. 1023 |
![]() |
||||
C00007739
![]() |
Acetylepibaptifoline
/ O-Acetylepibaptifoline |
No. 1023 |
![]() |
||||
C00007741
![]() |
(-)-Clathrotropine
|
No. 1023 |
![]() |
||||
C00007730
![]() |
Leontidine
|
No. 1023 |
![]() |
||||
C00002208
![]() |
Nuttalline
/ 7-Hydroxylupanine / 4-beta-Hydroxylupanine |
C035706
|
No. 1023 |
![]() |
|||
C00007734
![]() |
Anagyrine
/ (-)-Anagyrine |
CHEMBL203399
CHEMBL509692 CHEMBL1324708 CHEMBL1454284 |
C012736
|
7 / 8 / 11 | No. 1023 |
![]() |
|
C00007732
![]() |
Camoensine
|
No. 1023 |
![]() |
||||
C00026334
![]() |
Lamprolobine
|
No. 1023 |
![]() |
||||
C00023307
![]() |
Aphyllidine
|
No. 1211 |
![]() |
||||
C00007782
![]() |
(-)-Argyrolobine
/ 2-(R)-Hydroxyaphyllidine |
No. 1211 |
![]() |
||||
C00007760
![]() |
7-Hydroxysparteine
|
No. 1211 |
![]() |
||||
C00007695
![]() |
3beta,4alpha-Dihydroxy-13beta-methoxylupanine
|
No. 1211 |
![]() |
||||
C00007751
![]() |
Spartein
/ (-)-Spartein |
CHEMBL412873
CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 |
D013034
|
93 / 50 / 48 | 1 / 2 | No. 1211 |
![]() |
C00007758
![]() |
7-Hydroxypusilline
/ (-)-7-Hydroxy-beta-isosparteine |
No. 1211 |
![]() |
||||
C00026318
![]() |
(+)-Epilupinine
|
CHEMBL459397
CHEMBL1435718 |
1 / 1 / 1 | No. 1211 |
![]() |
||
C00026281
![]() |
Lupanine N-oxide
|
No. 1211 |
![]() |
||||
C00025362
![]() |
5,6-Dehydrolupanine
|
No. 1268 |
![]() |
||||
C00007705
![]() |
12-Hydroxycytisine
|
No. 1268 |
![]() |
||||
C00007709
![]() |
Caulophylline
/ N-Methylcytisine / (-)-N-Methylcytisine |
CHEMBL66191
CHEMBL1085045 |
C034245
|
No. 1268 |
![]() |
||
C00007707
![]() |
N-Formylcytisine
/ (-)-N-Formylcytisine |
CHEMBL1396784
CHEMBL1433686 |
4 / 6 / 11 | No. 1268 |
![]() |
||
C00002217
![]() |
Calpurmenine
|
No. 1268 |
![]() |
||||
C00007746
![]() |
13-Epihydroxysparteine
/ 13beta-Hydroxysparteine / 13-Epi-hydroxysparteine |
No. 1636 |
![]() |
||||
C00007745
![]() |
Deoxonuttaline
/ 4alpha-Hydroxysparteine / (-)-4alpha-Hydroxysparteine |
No. 1636 |
![]() |
||||
C00007721
![]() |
Ethyl cytisine-12-carboxylate
/ 12-Carboxycytisine ethyl ester |
No. 1636 |
![]() |
||||
C00007719
![]() |
12-Cytisineacetamide
|
CHEMBL508431
|
No. 1636 |
![]() |
|||
C00002214
![]() |
Camoensidine
|
No. 1636 |
![]() |
||||
C00025367
![]() |
(2R,9R)-Dihydroxyaphyllidine
|
No. 1636 |
![]() |
||||
C00007779
![]() |
Argyrolobine
/ 2(R)-Hydroxyaphyllidine |
No. 1838 |
![]() |
||||
C00025366
![]() |
(2S,9R)-Dihydroxyaphyllidine
|
No. 1838 |
![]() |
||||
C00026303
![]() |
13alpha-(Cinnamoyloxy)-lupanine
|
No. 1838 |
![]() |
||||
C00002226
![]() |
Matrine
/ (+)-Matrine |
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
C034244
|
5 / 3 / 7 | 4 / 5 | No. 1838 |
![]() |
C00025369
![]() |
5,6-Dehydrosparteine
|
C044693
|
No. 1838 |
![]() |
|||
C00007678
![]() |
Deoxylupanoline
/ Anhydrodihydrolupanoline / 10-Oxo-beta-isosparteine / 17-Oxo-beta-isosparteine |
CHEMBL509343
|
No. 1838 |
![]() |
|||
C00028194
![]() |
Argentine
|
No. 2032 |
![]() |
||||
C00001943
![]() |
13-Hydroxylupanine
/ (+)-13-Hydroxylupanine / (+)-13alpha-Hydroxylupanine |
CHEMBL518007
|
C091205
|
No. 2032 |
![]() |
||
C00001935
![]() |
13beta-Hydroxylupanine
|
CHEMBL518007
|
No. 2032 |
![]() |
|||
C00027863
![]() |
(-)-12,12'-Methylenedicytisine
|
No. 2032 |
![]() |
||||
C00001934
![]() |
13alpha-Hydroxyisolupanine
/ 13-Hydroxy-alpha-isolupanine |
CHEMBL518007
|
No. 2032 |
![]() |
|||
C00026292
![]() |
Cinevanine
|
No. 2957 |
![]() |
||||
C00007775
![]() |
13alpha-Hydroxymultiflorine
|
No. 2957 |
![]() |
||||
C00002223
![]() |
Allmatrine
/ 6-Allomatrine / 6beta-Matrine / (+)-Allomatrine / Tetrahydroisosophoramine |
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
5 / 3 / 7 | No. 2957 |
![]() |
||
C00026272
![]() |
11-Oxotetrahydrorhombifoline
|
No. 2957 |
![]() |
||||
C00032557
![]() |
Albine
|
CHEMBL514884
|
No. 3172 |
![]() |
|||
C00002210
![]() |
alpha-Isolupanine
|
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
No. 3172 |
![]() |
|||
C00007784
![]() |
Epiaphyllidine
/ 11-Epiaphyllidine |
No. 3172 |
![]() |
||||
C00002204
![]() |
Chamaetine
/ Epinuttaline / (+)-Chamaetine |
No. 5313 |
![]() |
||||
C00007754
![]() |
alpha-Isosparteine
|
CHEMBL412873
CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 |
93 / 50 / 48 | No. 5313 |
![]() |
||
C00001971
![]() |
3-Hydroxylupanine
|
No. 6163 |
![]() |
||||
C00002220
![]() |
13alpha-Methoxylupanine
|
No. 6875 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002207 C00002218 C00002224 C00002227 C00002236 C00002238 C00007681 C00007682 C00007735 C00007736 C00007757 C00023313 C00026289 C00026301 C00026325 C00026326 C00026329 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00002207 C00002218 C00002224 C00002227 C00002236 C00002238 C00007681 C00007682 C00007735 C00007736 C00007757 C00023313 C00026289 C00026301 C00026325 C00026326 C00026329 | 2 / 5 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002227 C00002236 C00007681 C00007682 C00007757 C00023313 C00026289 C00026301 C00026329 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002207 C00002218 C00002236 C00002238 C00007681 C00007682 C00026325 C00026326 C00026329 | 1 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002227 C00002236 C00007681 C00007682 C00007757 C00023313 C00026289 C00026301 C00026329 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002207 C00002218 C00002236 C00002238 C00007681 C00007682 C00026325 C00026326 C00026329 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002218 C00002236 C00007681 C00007682 C00007735 C00026325 C00026326 C00026329 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 0 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00002218 C00002236 C00007681 C00007682 C00026325 C00026326 C00026329 | 11 / 10 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002218 C00007758 C00026281 C00026325 C00026326 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002227 C00007757 C00023313 C00026289 C00026301 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002218 C00007758 C00026281 C00026325 C00026326 | 4 / 3 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002207 C00002218 C00002238 C00026325 C00026326 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 0 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002218 C00026275 C00026325 C00026326 C00026339 | 0 / 0 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002218 C00026275 C00026325 C00026326 C00026339 | 1 / 1 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002236 C00007681 C00007682 C00026329 | 5 / 9 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002236 C00007681 C00007682 C00026329 | 1 / 2 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002236 C00007681 C00007682 C00026329 | 2 / 2 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002236 C00007681 C00007682 C00026329 | 0 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002236 C00007681 C00007682 C00026329 | 1 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002236 C00007681 C00007682 C00026329 | 1 / 8 |
P17252 | Protein kinase C alpha type | Alpha | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002236 C00007681 C00007682 C00026329 | 2 / 2 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00002236 C00007681 C00007682 C00026329 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00002236 C00007681 C00007682 C00026329 | 2 / 1 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002236 C00007681 C00007682 C00026329 | 1 / 1 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002236 C00007681 C00007682 C00026329 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002236 C00007681 C00007682 C00026329 | 0 / 3 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002236 C00007681 C00007682 C00026329 | 2 / 1 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002236 C00007681 C00007682 C00026329 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002236 C00007681 C00007682 C00026329 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002236 C00007681 C00007682 C00026329 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002236 C00007681 C00007682 C00026329 | 2 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002236 C00007681 C00007682 C00026329 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002207 C00002238 C00007735 | 3 / 3 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002218 C00026325 C00026326 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002218 C00026325 C00026326 | 0 / 0 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002218 C00026325 C00026326 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002218 C00026325 C00026326 | 1 / 4 |
P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002218 C00026325 C00026326 | 2 / 1 |
P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002218 C00026325 C00026326 | 3 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 1 |
Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002218 C00026325 C00026326 | 3 / 2 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002226 C00007678 C00026303 | 1 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00002218 C00026325 C00026326 | 6 / 4 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002218 C00026325 C00026326 | 0 / 0 |
P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002218 C00026325 C00026326 | 2 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002207 C00002238 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00007758 C00026281 | 7 / 3 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00002218
|
1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
C00002218
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002218
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00002218
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002218
|
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00002218
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002227
|
4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog |
C00002227
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00002227
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002227
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00002236
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
#253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
#608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
#601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) Q07001 (related) |
H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001145 | Arrhythmias, Cardiac |
C00002214
C00002236 |
D006331 | Heart Diseases |
C00002227
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00002214
|
D014693 | Ventricular Fibrillation |
C00002214
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00002227
|
D002779 | Cholestasis |
C00002227
|
D056487 | Drug-Induced Liver Injury, Chronic |
C00002227
|
D012640 | Seizures |
C00002218
|
D008113 | Liver Neoplasms |
C00002227
|
D003092 | Colitis |
C00007758
|
D019694 | Hepatitis B, Chronic |
C00007758
|
D007249 | Inflammation |
C00007758
|
D008106 | Liver Cirrhosis, Experimental |
C00007758
|
D054537 | Atrioventricular Block |
C00002236
|